Over recent years, an increasing number of studies have suggested that the female sex hormone estrogen (E2) elicits neuroprotective functions, which are lost upon menopause, and that this loss may at least partly account for the increased female prevalence of Alzheimer’s disease (AD) [1–3]. Here, PLXNA3 is linked to Alzheimer disease.